• Explore /
  • Poster
  • / Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).

Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).

Abstract Poster

Authors

Silvia Stacchiotti

Silvia Stacchiotti

IRCCS Foundation National Cancer Institute, Milan, Italy

Silvia Stacchiotti , Giovanni Grignani , Bruno Vincenzi , Ignazio Carreca , Emanuela Palmerini , Paola Collini , Angelo Paolo Dei Tos , Gianpaolo Dagrada , Nadia Zaffaroni , Alessandro Gronchi , Gianluca Ignazzi , Viviana Appolloni , Matilde Ingrosso , Anna Maria Frezza , Paolo Giovanni Casali , Carlo Morosi , Luigi Mariani , Giacomo Giulio Baldi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03023124

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11571)

DOI

10.1200/JCO.2023.41.16_suppl.11571

Abstract #

11571

Poster Bd #

505

Abstract Disclosures

Similar Posters

First Author: Maristella Saponara

First Author: Silvia Stacchiotti

First Author: Mario Javier Pineda

First Author: Imane H. El Dika